186 related articles for article (PubMed ID: 23573823)
1. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation.
Santos FP; Tam CS; Kantarjian H; Cortes J; Thomas D; Pollock R; Verstovsek S
Leuk Lymphoma; 2014 Jan; 55(1):121-7. PubMed ID: 23573823
[TBL] [Abstract][Full Text] [Related]
2. [Role of splenectomy in the treatment of myelofibrosis].
Melikian AL; Kolosova LIu; Sokolova MA; Kovrigina AM; Silaev MA; Giliazitdinova EA; Gemdzhian ÉG; Karagiulian SR
Ter Arkh; 2013; 85(8):69-76. PubMed ID: 24137967
[TBL] [Abstract][Full Text] [Related]
3. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy for myeloproliferative disorders.
Wilson RE; Rosenthal DS; Moloney WC; Osteen RT
World J Surg; 1985 Jun; 9(3):431-6. PubMed ID: 4013356
[No Abstract] [Full Text] [Related]
5. The Impact of Splenectomy in Myelofibrosis Patients before Allogeneic Hematopoietic Stem Cell Transplantation.
Robin M; Zine M; Chevret S; Meignin V; Munoz-Bongrand N; Moatti H; Xhaard A; Sicre de Fontbrune F; Peffault de Latour R; Sarfati E; Socié G
Biol Blood Marrow Transplant; 2017 Jun; 23(6):958-964. PubMed ID: 28263921
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications.
Malato A; Rossi E; Tiribelli M; Mendicino F; Pugliese N
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):588-595. PubMed ID: 32482540
[TBL] [Abstract][Full Text] [Related]
7. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
[TBL] [Abstract][Full Text] [Related]
8. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
Akpek G; McAneny D; Weintraub L
J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
[TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
Lafaye F; Rain JD; Clot P; Najean Y
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
[TBL] [Abstract][Full Text] [Related]
10. Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
Sankar K; Pettit K
Curr Hematol Malig Rep; 2020 Oct; 15(5):391-400. PubMed ID: 32827272
[TBL] [Abstract][Full Text] [Related]
11. [Splenectomy in 5 patients with idiopathic myelofibrosis].
Nozato A; Mizorogi F; Fukumi S; Watanabe H; Kobayashi M
Rinsho Ketsueki; 2001 Aug; 42(8):627-32. PubMed ID: 11579502
[TBL] [Abstract][Full Text] [Related]
12. Massive splenomegaly.
Johnson HA; Deterling RA
Surg Gynecol Obstet; 1989 Feb; 168(2):131-7. PubMed ID: 2911790
[TBL] [Abstract][Full Text] [Related]
13. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
[TBL] [Abstract][Full Text] [Related]
14. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
Petroianu A
Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy in the chronic myeloproliferative syndromes. A retrospective risk-versus-benefit analysis.
Jacobs P; Wood L; Dent DM
S Afr Med J; 1992 May; 81(10):499-503. PubMed ID: 1585220
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country.
Zvizdic Z; Kovacevic A; Milisic E; Jonuzi A; Vranic S
PLoS One; 2020; 15(8):e0237016. PubMed ID: 32756575
[TBL] [Abstract][Full Text] [Related]
17. Splenectomy and hemopoietic stem cell transplantation for myelofibrosis.
Li Z; Gooley T; Applebaum FR; Deeg HJ
Blood; 2001 Apr; 97(7):2180-1. PubMed ID: 11286221
[No Abstract] [Full Text] [Related]
18. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
Brenner B; Nagler A; Tatarsky I; Hashmonai M
Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy for massive splenomegaly: long-term results and risks for mortality.
Taner T; Nagorney DM; Tefferi A; Habermann TM; Harmsen WS; Slettedahl SW; Donohue JH
Ann Surg; 2013 Dec; 258(6):1034-9. PubMed ID: 23222031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
